Assessment of response to treatment in advanced breast cancer. British Breast Group.

Suppr

超能文献

出版信息

Lancet. 1974 Jul 6;2(7871):38-9.

PMID:4134716

Abstract

摘要

相似文献

Assessment of response to treatment in advanced breast cancer. British Breast Group.

Lancet. 1974 Jul 6;2(7871):38-9.

Breast cancer. The breast test on trial.

Nurs Times. 1987;83(40):27-9.

[Clinical aspects, mammography, cytology, stamp-biopsy and thermography in breast diagnostics].

Fortschr Geb Rontgenstr Nuklearmed. 1973;0(0):suppl:201-2.

[Errors in the diagnosis of breast cancer].

Sov Med. 1989(11):95-9.

[Suspicious findings in the female breast].

Helv Chir Acta. 1973 Dec;40(5):641-9.

Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?乳腺钼靶和超声检查发现的可触及的边界清晰的非钙化实性乳腺肿块的随访：能否避免活检？

Radiology. 2004 Dec;233(3):850-6. doi: 10.1148/radiol.2333031845. Epub 2004 Oct 14.

[The significance of mammography in surgical hospital practice].

Ugeskr Laeger. 1981 Feb 2;143(6):336-40.

[Early diagnosis of breast neoplasms].[乳腺肿瘤的早期诊断]

Med Klin. 1970 Oct 9;65(41):1765-70.

[New trends in diagnosis and therapy of breast cancer].[乳腺癌诊断与治疗的新趋势]

Minerva Med. 1973 Apr 18;64(25):1306-19.

[Clincial certainty in the diagnosis of breast cancer].

Z Arztl Fortbild (Jena). 1975 Oct 15;69(20):1049-54.

引用本文的文献

Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.老年女性雌激素受体阴性的早期可手术原发性乳腺癌——生物学特征及长期临床结局

PLoS One. 2017 Dec 28;12(12):e0188528. doi: 10.1371/journal.pone.0188528. eCollection 2017.

Role of goserelin in combination with endocrine therapy for the treatment of advanced breast cancer in premenopausal women positive for hormone receptor: a retrospective matched case-control study.戈舍瑞林联合内分泌治疗用于激素受体阳性绝经前晚期乳腺癌的疗效：一项回顾性匹配病例对照研究。

Cancer Biother Radiopharm. 2013 Dec;28(10):697-702. doi: 10.1089/cbr.2012.1436. Epub 2013 Jun 27.

Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer.“撤疗”作为乳腺癌激素干预形式的临床相关性。

World J Surg Oncol. 2011 Sep 9;9:101. doi: 10.1186/1477-7819-9-101.

Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre.老年女性雌激素受体阳性可手术原发性乳腺癌的长期临床结局：来自单个中心的大型系列研究。

Br J Cancer. 2011 Apr 26;104(9):1393-400. doi: 10.1038/bjc.2011.105. Epub 2011 Mar 29.

Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents.高剂量“炔雌醇”在接受过大量内分泌药物预处理的绝经后晚期乳腺癌患者中的疗效和耐受性。

World J Surg Oncol. 2006 Jul 11;4:44. doi: 10.1186/1477-7819-4-44.

"Resurrection of clinical efficacy" after resistance to endocrine therapy in metastatic breast cancer.转移性乳腺癌内分泌治疗耐药后的“临床疗效复苏”

World J Surg Oncol. 2006 Jul 5;4:40. doi: 10.1186/1477-7819-4-40.

Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.第二代和第三代芳香化酶抑制剂作为绝经后转移性乳腺癌患者的一线内分泌治疗：随机试验的汇总分析

Br J Cancer. 2006 Jun 19;94(12):1789-96. doi: 10.1038/sj.bjc.6603194. Epub 2006 May 30.

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.戈舍瑞林联合阿那曲唑作为绝经前晚期乳腺癌二线内分泌治疗的临床及内分泌学数据。

Br J Cancer. 2004 Feb 9;90(3):590-4. doi: 10.1038/sj.bjc.6601557.

Prognostic factors for patients with hepatic metastases from breast cancer.乳腺癌肝转移患者的预后因素。

Br J Cancer. 2003 Jul 21;89(2):284-90. doi: 10.1038/sj.bjc.6601038.

Biological factors of prognostic significance in locally advanced breast cancer.

Breast Cancer Res Treat. 1994;29(3):259-64. doi: 10.1007/BF00666479.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验